Literature DB >> 11952707

Widespread skin-limited adult Langerhans cell histiocytosis: long-term follow-up with good response to interferon alpha.

S E Chang1, G J Koh, J H Choi, K H Lee, K J Sung, K C Moon, J K Koh.   

Abstract

Langerhans cell histiocytosis (LCH) most frequently involves bone, but also involves the skin in 40% of cases; in 10% of patients it is limited to the skin. Cutaneous findings of skin-limited LCH are scaly papules, vesicles, nodules, tumours with erosion, ulceration, or crusting and/or purpura. We report a case of widespread adult-onset LCH confined to skin in which topical carmustine, photochemotherapy, systemic steroids, and 2-chlorodeoxyadenosine were only partially effective. However, longer remission was achieved by the use of subcutaneous interferon-alpha2b.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952707     DOI: 10.1046/j.1365-2230.2002.00989.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Differentiating skin-limited and multisystem Langerhans cell histiocytosis.

Authors:  Stephen J Simko; Benjamin Garmezy; Harshal Abhyankar; Philip J Lupo; Rikhia Chakraborty; Karen Phaik Har Lim; Albert Shih; M John Hicks; Teresa S Wright; Moise L Levy; Kenneth L McClain; Carl E Allen
Journal:  J Pediatr       Date:  2014-10-21       Impact factor: 4.406

2.  Photodynamic therapy for multi-resistant cutaneous Langerhans cell histiocytosis.

Authors:  Valérie Failla; Odile Wauters; Marie Caucanas; Nazli Nikkels-Tassoudji; Arjen F Nikkels
Journal:  Rare Tumors       Date:  2010-06-30

3.  Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient.

Authors:  Shinsaku Imashuku; Miyako Kobayashi; Yoichi Nishii; Keisuke Nishimura
Journal:  Case Rep Dermatol Med       Date:  2018-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.